The 2012 Nobel Prize in chemistry has been awarded to National Institutes of Health grantees Robert J. Lefkowitz, M.D., of the Howard Hughes Medical Institute and Duke University Medical Center, Durham, N.C.; and Brian K. Kobilka, M.D., of the Stanford University School of Medicine, Stanford, Calif., for studies of protein receptors that let body cells sense and respond to outside signals.
Related posts:
- NIH Grantee Wins 2010 Nobel Prize in Chemistry The 2010 Nobel Prize in chemistry has been awarded to National Institutes of Health (NIH) grantee Ei-ichi Negishi, Ph.D., of Purdue University, West Lafayette, Indiana. Dr. Negishi shares the award with Richard F. Heck, Ph.D., of the University of Delaware in Newark, Delaware and Akira Suzuki, Ph.D., of Hokkaido University, Sapporo, Japan. The three researchers […]...
- 2011 Nobel Prize in physiology or medicine The 2011 Nobel Prize in Physiology or Medicine has been awarded to National Institutes of Health grantees Bruce A. Beutler, M.D., of The Scripps Research Institute, La Jolla, Calif.; and Jules A. Hoffmann, Ph.D., for their discoveries concerning the activation of innate immunity and the late Ralph M. Steinman, M.D., of Rockefeller University, New York […]...
- Stanford researcher to speak at NIH on the role of neuroimaging in understanding pain Sean Mackey, M.D., Ph.D., chief of the Pain Management Division and associate professor of anesthesia and pain management at the Stanford University School of Medicine, Stanford, Calif., will be the featured speaker for the third annual Stephen E. Straus Distinguished Lecture in the Science of Complementary and Alternative Medicine....
- Patient-derived stem cells could improve drug research for Parkinson’s Researchers have taken a step toward personalized medicine for Parkinson’s disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health....
- NIGMS Challenge Grant Projects NIGMS Challenge Grant projects...
- Director of Intramural Center for Regenerative Medicine National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has announced the appointment of Mahendra S. Rao, M.D., Ph.D. as the director for the new NIH Intramural Center for Regenerative Medicine (NIH-CRM). The NIH-CRM is an initiative to create a world-class center of excellence in stem cell technology on the NIH campus, including induced […]...
- How Medicare Coverage Can Help – Gene Mutations Linked to Early-Onset Inflammatory Bowel Disease An international team has discovered that mutations in either of 2 related genes cause a severe and rare form of inflammatory bowel disease in young children. The discovery allowed the researchers to successfully treat one of the study patients with a bone marrow transplant....
- Medicare Card, Statement on World Malaria Day — April 25, 2012 On World Malaria Day, we stand at a critical juncture in our efforts to control a global scourge. This year’s theme “Sustain Gains, Save Lives: Invest in Malaria” stresses the crucial role of continued investment of resources to maintain hard-won gains. Lives have indeed been saved....
- Level of tumor protein indicates chances cancer will spread Researchers at the National Institutes of Health and the University of Hong Kong have discovered that high levels of a particular protein in cancer cells are a reliable indicator that a cancer will spread....
- Scientists find approach to enhance and prolong immune attack against tumor cells Investigators have identified a new class of human immune cells that behave like stem cells. These cells, a subtype of T lymphocytes, which comprise a small fraction of white blood cells, may prove more effective than any previously reported type of T cell for treating tumors. The study, by scientists at the National Cancer Institute […]...
- Recovery Act Funding, the NIEHS Supports Grantees Across the Country Recovery Act funding, the NIEHS supports grantees across the country working on issues related to nanotechnology...
- Medicare, Medicare Card, NIH and Wellcome Trust Announce Partnership To Support Population-based Genome Studies in Africa The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria. […]...
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- NCCAM’s Advisory Council welcomes six new members The National Center for Complementary and Alternative Medicine (NCCAM) welcomes six new members to the National Advisory Council for Complementary and Alternative Medicine. The council serves as the principal advisory body to NCCAM, the lead federal agency for research on complementary medicine, and a component of the National Institutes of Health....
- Gene Mutations Linked to Early-Onset Inflammatory Bowel Disease An international team has discovered that mutations in either of 2 related genes cause a severe and rare form of inflammatory bowel disease in young children. The discovery allowed the researchers to successfully treat one of the study patients with a bone marrow transplant....
Posted in MedicareCard Replacement | Tags: MEDICARE CARD